×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
HANDLING CONFLICT OF INTEREST (COI)
Session Chair(s)
Noël Wathion, RPh
Deputy Executive Director
European Medicines Agency, Netherlands
Patients and experts are increasingly involved in drug regulatory assessment. Transparency in the management of potential conflict of interest is of paramount importance. The session also elaborates on finding the right balance between minimising conflicts of interests versus the availability of the best possible expertise.
Speaker(s)
EMA Handling of Conflicts of Interests: Current status and how to move forward
Noël Wathion, RPh
European Medicines Agency, Netherlands
Deputy Executive Director
Searching for the Perfect Expert: Regulatory and academic experience
Gonzalo Calvo Rojas, PhD
Hospital Clinic Barcelona, Spain
Consultant in Clinical Pharmacology
Interaction between Industry and Academia: Impact of conflicts of interest
Ruth Diazaraque-Marin
Giliead Sciences, United Kingdom
Senior Medical Affair Director Southern Europe
Have an account?